Such low immunogenic sub-clones are often affected by loss of antigen presentation, due to a defective antigen- presenting machinery (36), hampering the recognition of tumor antigens by conventional (CD4+ and CD8+) and unconventional T cells (37). Here, CD4 is linked to neoplasm.